Bulletin
Investor Alert

Pfizer Inc.

NYS: PFE

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Pfizer Inc.

After Hours

PFE
/zigman2/quotes/202877789/composite

$

40.52

Change

+0.01 +0.02%

Volume

Volume 2.40m

Jan 17, 2020, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202877789/composite

Previous close

$ 40.61

$ 40.51

Change

-0.10 -0.25%

Day low

Day high

$40.42

$40.81

Open
Open: 40.57

52 week low

52 week high

$33.97

$44.56

Open

Market cap

$224.19B

Average volume

19.04M

P/E ratio

14.16

Rev. per Employee

$580,595

EPS

2.86

Dividend

0.38

Div yield

3.75%

Ex dividend date

1/30/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pfe

MarketWatch News on PFE

  2. Dow up 75 points on gains for UnitedHealth, Visa stocks

    3:23 p.m. Jan. 15, 2020

    - Automated Insights

  3. UnitedHealth, Pfizer share gains lead Dow's 150-point climb

    10:48 a.m. Jan. 15, 2020

    - Automated Insights

  4. Dow's 75-point climb led by gains in UnitedHealth, Pfizer stocks

    9:47 a.m. Jan. 15, 2020

    - Automated Insights

  12. For Dividend Growth, Consider Health-Care and Tech Stocks

    6:45 a.m. Jan. 9, 2020

    - Lawrence C. Strauss

  13. It’s Time to Buy Bristol-Myers Stock, According to 1 Analyst.

    9:17 a.m. Jan. 7, 2020

    - Josh Nathan-Kazis

  18. Where to Find Yield in Challenging Markets

    8:30 p.m. Jan. 3, 2020

    - Andrew Bary

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pfe

Other News on PFE

  1. The 4% Passive DGI Core Portfolio: The Year-End Review

    9:06 a.m. Jan. 18, 2020

    - Seeking Alpha

  4. Castle Could Crumble When IPO Lockup Expires

    9:07 a.m. Jan. 17, 2020

    - Seeking Alpha

  5. Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction

    7:47 a.m. Jan. 17, 2020

    - Zacks.com

  6. Why Amarin Stock Is Poised for a Healthy 2020

    6:30 a.m. Jan. 17, 2020

    - InvestorPlace.com

  7. Sangamo 2020: Gene Therapy Plus Optionality Equals Opportunity

    11:16 a.m. Jan. 16, 2020

    - Seeking Alpha

  9. US Indexes Close Higher Wednesday with China Trade Deal Signing

    9:32 a.m. Jan. 16, 2020

    - GuruFocus.com

  11. Beyond the Growing Dividend, Abbvie Stock Is a Good Buy Here

    8:27 a.m. Jan. 16, 2020

    - InvestorPlace.com

  12. After FDA Approval, Amarin Stock Is Stuck in Worrisome Trading

    7:30 a.m. Jan. 16, 2020

    - InvestorPlace.com

  13. Pfizer's Dividend Payout Is Well-Protected

    8:59 p.m. Jan. 15, 2020

    - Seeking Alpha

  14. Ocugen Stock Is Not for the Faint of Heart

    1:25 p.m. Jan. 15, 2020

    - InvestorPlace.com

  15. Mylan up 3% on bullish forecast for Viatris

    12:19 p.m. Jan. 15, 2020

    - Seeking Alpha

  16. Pfizer Stock Offers Good Value to Patient Investors

    11:37 a.m. Jan. 15, 2020

    - InvestorPlace.com

  19. ViiV Healthcare's Dovato OK'd in Japan

    6:49 a.m. Jan. 15, 2020

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/pfe

Press Releases on PFE

  1. Global Complex Disease Treatment Market worth US$ XX Billion by 2029

    12:01 a.m. Today

    - Xherald

  13. Cold Remedies Market : Good Value & Room to Grow Ahead Seen

    2:44 a.m. Jan. 18, 2020

    - marketresearch.biz

  17. Global Cold Packs Market worth US$ XX Billion by 2029

    12:01 a.m. Jan. 18, 2020

    - Xherald

  20. Thromboplastin Market in Global : Current and the Future Trends

    5:47 p.m. Jan. 17, 2020

    - Market Research Analyst

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.